ASCO Annual Meeting

2024 ASCO Annual Meeting

ODA-ASCO 2024-Chyke Doubeni, MD, MPH-Part 2_960x800
ODA-Expert Perspectives-Matthew Hadfield, DO_960x800
ODA-ASCO 2024-Chyke Doubeni, MD, MPH-Part 1_960x800
Fellows Forum-Thejal Srikumar, MD_960x800
2024-Best of ASCO 2024-Expert Panel_960x800
Fellows Forum-Sharafeldin and Haque_960x800
Fellows Forum-ASCO 2024-Mistry and Patel_960x800
ODA-ASCO 2024-Natalie Jackson-Carroll, PhD, APRN, FNP-C_960x800
Fellows Forum-Jessica Bauman, MD_960x800
1 2 3 4 5

2023 ASCO Annual Meeting

Timothy Cloughesy discusses his presentation at ASCO 2023 regarding the INDIGO study, of which he is the senior author.
Dr. Stephen Freedland discusses his ASCO abstract on real-world characteristics and treatment in metastatic CSPC.
Lalan Wilfong discusses his presentation concerning payment reform in the Oncology Care Model and the Enhancing Oncology Model.
Janet Espirito, PharmD, discusses real-world end points for assessing response to non–small cell lung cancer therapies.
Robin Lally and Marilyn Hammer discuss their ASCO abstract on coaching cancer survivors through digital health.
Mandi Pratt-Chapman discusses her ASCO 2023 study on sexual orientation and gender identity data collection in oncology.
Manoj Bupathi talks about his presentations this year concerning the efficacy and safety of sacituzumab govitecan in urothelial cancer.
1 2 3 4

2022 ASCO Annual Meeting

In this interview, Cherry Au discusses her ASCO presentation in which she us about the need for medical student confidence when treating LGBTQIA+ patients.
Megan-Claire Chase shares the story of her breast cancer journey and her advocacy work with SHARE Cancer Support.
Urvi Shah gives an overview of the ASCO posters on multiple myeloma treatments and her work in nutritional interventions.
In this interview, Dan Gombos discusses the field of ocular oncology and how to manage and treat tumors that start or spread to the eye.
In this interview, Kathi Mooney discusses her presentation and abstract about remote symptom management and the Huntsman at Home Rural Experience.
In this interview, Mark Fleming discusses his ASCO presentation about the initiative to foster a culture of inclusion in oncology practice.
Jon Wetzel and Leif Honda of TriMetis Life Sciences discuss pathology, artifical intelligence, and tissue-based research.
Dr. Sam Kareff discusses his ASCO poster on the prognosis of HRAS mutations in breast cancer and their role in treatment.
1 2 3 4